Safety and efficacy of cell therapies administered in the acute/subacute and chronic phases after stroke: a meta-analysis

dc.contributor.authorUnsworth, D.J.
dc.contributor.authorMathias, J.L.
dc.contributor.authorDorstyn, D.
dc.contributor.conference10th World Stroke Congress (26 Oct 2016 - 29 Oct 2016 : Hyderabad, India)
dc.date.issued2016
dc.descriptionFree Communications 2: Experimental and Translational Neuroscience Article 57 WSC-0060
dc.description.statementofresponsibilityD. J. Unsworth, J. L. Mathias and D. Dorstyn
dc.identifier.citationInternational Journal of Stroke, 2016, vol.11, iss.3 Suppl., pp.25-25
dc.identifier.doi10.1177/1747493016670567
dc.identifier.issn1747-4930
dc.identifier.issn1747-4949
dc.identifier.orcidUnsworth, D.J. [0000-0002-2167-9409]
dc.identifier.orcidMathias, J.L. [0000-0001-8957-8594]
dc.identifier.orcidDorstyn, D. [0000-0002-7799-8177]
dc.identifier.urihttp://hdl.handle.net/2440/105753
dc.language.isoen
dc.publisherSage Publications
dc.rights© 2016 World Stroke Organization
dc.source.urihttps://doi.org/10.1177/1747493016670567
dc.titleSafety and efficacy of cell therapies administered in the acute/subacute and chronic phases after stroke: a meta-analysis
dc.typeConference item
pubs.publication-statusPublished

Files